Short-Term Performance of the Transcatheter Melody Valve in High-Pressure Hemodynamic Environments in the Pulmonary and Systemic Circulations
Ventricular outflow tract
Pulmonary valve
Cardiac catheterization
DOI:
10.1161/circinterventions.111.963389
Publication Date:
2011-11-10T06:29:45Z
AUTHORS (9)
ABSTRACT
Background— The Melody valve is approved for percutaneous pulmonary replacement in dysfunctional right ventricular outflow tracts. function of this when subjected to high-pressure loads humans unknown. aim study was describe the immediate and short-term results valves implanted a environment. Methods Results— Definitions system were established systemic (ie, aortic or mitral position) tract conduit tricuspid annulus) circulations. Implants these environments ascertained from databases 5 centers that participated US Investigational Device Exemption trial. Thirty implants met inclusion criteria: 23 circulation (all (5 native position, 1 left ventricle-to-descending aorta conduit, annulus). All performed percutaneously catheterization laboratory. A hybrid approach (surgical exposure transcatheter implant) used 4 implants. There no procedure-related deaths. Three patients died nonprocedure- nonvalve-related causes. At year, freedom moderate severe regurgitation 100%, mild 90%. Freedom stenosis 86% at year. Conclusions— Short-term performance encouraging, with good all patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (12)
CITATIONS (83)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....